Anticoagulation in cancer-related thrombosis: Evidence from the trials

Anticoagulation in cancer-related thrombosis: Evidence from the trials

HaematologyOncologyCardiology
A badge with ribbon in color black CME Unit: 1 point | An analog clock in color black 1 Hour | A black calendar with white triangle in center that has a black exclamation point in the middle 10 Dec 2024 

Overview

About this course

Cancer-associated thrombosis (CAT) is one of the leading causes of morbidity and mortality in cancer patients. The management of CAT with anticoagulation therapy has evolved over the past two decades. While low molecular weight heparins (LMWHs) have been the standard of care, emerging evidence has demonstrated direct oral anticoagulants (DOACs) as an effective option for the management of CAT.

In this lecture, Professor John Eikelboom presented an overview of the treatment landscape for CAT, and reviewed current clinical and real-world evidence for DOACs for the management of CAT. Professor Eikelboom also highlighted current guideline recommendations and discussed considerations in choosing an appropriate anticoagulant for venous thromboembolism (VTE) patients with cancer.

Learning outcomes

Upon completion of this module, participants will have a better understanding of the following aspects:

  • Treatment landscape and guideline recommendations for the management of VTE patients with cancer
  • Current evidence of DOACs from randomized controlled trials
  • Considerations when choosing an appropriate DOAC for VTE patients with cancer

Topics covered

  • Risk of VTE in cancer patients
  • Anticoagulation therapy for the management of CAT
  • Clinical trials of DOACs: Key efficacy and safety data
  • Challenges in treating patients with CAT
  • Thromboprophylaxis for primary prevention of VTE: Key clinical data
  • Real-world evidence for the use of DOACs
  • Guideline recommendations for the management of CAT

1 CME Point Available

  • This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
    • This module is accredited for both Hong Kong Doctors Union (HKDU) members and non-members.
  • This module is accredited for 1 CME point for fellows of the Hong Kong College of Radiologists, Hong Kong College of Community Medicine, Hong Kong College of Emergency Medicine, and Hong Kong College of Physicians.
  • Please note that this module will not earn CME credit for fellows of colleges not listed here.
  • A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.

PP-ELI-HKG-1222 AUG 2023

Something went wrong.